Listen to Coronavirus Patient Zero
Commercialization of BioPharma Products in the USA-A Practical Guide (2nd Edition) The discovery, development, and commercialization of a biopharmaceutical product are highly complex processes. The product manufacturing, distribution, and marketing activities must be flawlessly executed to ensure commercial success The commercial environment requires collaboration with diverse stakeholders such as patients, providers, payers, and policy makers to create value for the product. The commercial success of a product is critical in maximizing its potential and the shareholder return. This book outlines commercial imperatives, strategic choices, as well as cardinal imperatives for success along each step of the BioPharma value chain. It shows how pharmaceutical and biotechnology companies can achieve differentiated positioning for their products in this value-driven competitive healthcare environment in the USA. It's intended for anyone involved in commercial decisions in the BioPharma sector.
All laws are modified by future legislatures, and the Affordable Care Act (ACA) will not be an exception. Healthcare organizations must be prepared to respond as the law evolves. Responding to Healthcare Reform clarifies the complexities of the ACA by explaining the underlying theories that shaped it, describing the act's impact on the role of the healthcare organization, and offering direction for strategy formulation. Written for healthcare executives, it focuses on the sections of the bill that are most pertinent to provider operations. Because the ACA creates an uncertain environment, this book is stocked with a variety of tools to help healthcare executives predict change and recalibrate strategies. You will benefit from: * Pactical analysis of key aspects of the bill and how they will impact providers * Descriptions of 20 possible scenarios that can be used to test the viability of strategies under various conditions * Access to a continuously updated companion website that includes sources for strategy implementation
Disinfection By-Products in Water Treatment describes new government regulations related to disinfection by-products. It explains the formation of microorganism by-products during water treatment and the methods employed to control them.
Oze Pharmacy Articles
Oze Pharmacy Books